Pharma Exclusives Pressreleases
Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
Monday, April 28, 2025Eton Pharmaceuticals Incan innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases today announced the submission of a New Drug Application NDA to the US Food and Drug Administration
Thermo Fisher Scientific Leverages Integrated Solutions to Accelerate the Development of Biologic Therapeutics
Monday, April 28, 2025Thermo Fisher Scientific the world leader in serving science is employing an enhanced platform technology and a new CHO K cell line that can reduce timelines to Investigational New Drug IND filing from to nine months
Thermo Fisher Scientific Invests to Enhance U.S. Innovation and Support Customers’ Manufacturing
Thursday, April 24, 2025Thermo Fisher Scientific Inc the world leader in serving science will invest an additional billion in the United States over the next four years strengthening American innovation manufacturing and economic competitiveness across the life sciences se...
Cybin Announces Additional Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Phase 3 Program Evaluating CYB003
Wednesday, April 23, 2025Cybin Inc a clinicalstage breakthrough neuropsychiatry platform company committed to revolutionizing mental healthcare by developing new and innovative nextgeneration treatment options today announced additional strategic partnership agreements
Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs
Monday, April 21, 2025Cybin Inc a clinicalstage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative nextgeneration treatment options today announced a strategic partnership
Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center in Greater San Diego to Help Accelerate Cell Therapy Development
Thursday, April 17, 2025Thermo Fisher Scientific Inc the world leader in serving science today announced the grand opening of its Advanced Therapies Collaboration Center ATxCC in Carlsbad Calif This advanced facility is designed to accelerate the development
Aptar Announces Clinical Validation Study to Accelerate US FDA Approval of SmartTrack™ In-Vitro-in-Silico Platform for Pressurized Metered-Dose Inhalers
Wednesday, April 16, 2025AptarGroup Inc a global leader in drug and consumer product dosing dispensing and protection technologies today announces the commencement of a clinical study to validate its proprietary SmartTrack platform
Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial
Tuesday, April 15, 2025Bristol Myers Squibbtoday announced the Phase ODYSSEYHCM trial evaluating Camzyos mavacamten for the treatment of adult patients with symptomatic New York Heart Association NYHA class IIIII nonobstructive hypertrophic cardiomyopathy nHCM did not mee...
Inozyme Pharma Announces JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency
Thursday, April 10, 2025Inozyme Pharma Inca clinicalstage biopharmaceutical company developing innovative therapeutics for rare diseases that affect bone health and blood vessel function today announced the publication of a paper titled Phenotypic characterization of ENPP d...
Tonix Pharmaceuticals to Work with Makana Therapeutics on Preclinical and Clinical Xenotransplantation Studies Using TNX-1500 and Genetically Engineered Organs
Wednesday, April 09, 2025Tonix Pharmaceuticals Holding Corpa fullyintegrated biopharmaceutical company with marketed products and a pipeline of development candidates and Makana Therapeutics Inc Makana a global leader in the field of xenotransplantation today announced a col...
